Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.
Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality (Ataraxis™ Tau), foundation model (Falcon and Kestrel for digital pathology), and survival analysis research.
Our first clinical products, such as Ataraxis™ Breast for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.
At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.
Ataraxis has raised over $24 million in funding, including a $20 million Series A led by top venture capital funds such as Thiel Capital/Founders Fund (OpenAI, SpaceX, Palantir), Obvious Ventures (AMI Labs, Inceptive, Radical Numerics, Recursion), and AIX Ventures (Hugging Face, Perplexity).
We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.
ResponsibilitiesYou will lead expansion of Ataraxis’s offerings to one of the next cancer types and disease areas beyond breast cancer. Ataraxis has already developed a pan-cancer AI platform that has been internally validated to perform well across various tumor types. This role will work on creating the right environment for the commercial launch in the next cancer type(s). In that process, you will:
Develop and manage a network of relationships with key opinion leaders, clinical advisors, early adopters, and research collaborators to identify potential customers and partners as well as validate hypotheses and gather insights
Develop internal knowledge (memos, draft collateral material) in preparation for medical affairs/sales teams in the future
Work directly with the CEO to execute on product launches in record speed
Source real-world datasets, clinical trial datasets, and biobank resources to support AI model development and evaluation
Partner with engineering and research teams to inform clinical-grade model development
PhD, MD, or a Master’s degree in cancer biology, molecular biology, cell biology, biomedical sciences, pharmacology, pharmaceutical sciences, or a related life sciences field. You need to be able to very quickly learn about new disease areas in depth independently
Strong soft skills and being able to speak to various audiences, from medical key opinion leaders to software engineers. Ideally, you should have experience presenting scientific content to medical/academic audiences
Good sense/taste for product, creative thinking, being able to apply modern product building frameworks to healthcare
Bias for action, ability to form independent thought on complex topics where you don't have a lot of information and will have to trust your intuition, thinking from first principles
Strongly preferred: 2+ years of industry experience (e.g.,: biotech, pharma, diagnostics, healthcare strategy, management consulting, or finance)